ASX:ILAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Island Pharmaceuticals Ltd
$0.435
$0.035 (7.45%)
Day Range
$0.430 – $0.465
52 Week Range
$0.145 – $0.630
Volume
353.13K
Avg Volume (10D)
683.85K
Market Cap
$128.72M
Price Chart
Market Statistics
Open$0.465
Previous Close$0.470
Day High$0.465
Day Low$0.430
52 Week High$0.630
52 Week Low$0.145
Valuation
Market Cap128.72M
Shares Outstanding295.92M
Price to Book18.04
Trading Activity
Volume353.13K
Value Traded156.20K
Bid$0.435 × 13,025
Ask$0.445 × 966
Performance
1 Day6.67%
5 Day28.00%
13 Week33.33%
52 Week200.00%
YTD11.63%
Technical Indicators
RSI (14)55.50
50-Day SMA$0.384
200-Day SMA$0.413
Latest News
Biotechnology
Island Pharmaceuticals Expands USAMRIID Agreement for Galidesivir Marburg Study
Island Pharmaceuticals expands USAMRIID CRADA to dose-optimise Galidesivir Marburg study; trials start next quarter; topline results H2 2026, a major milestone.
Biotechnology
Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement
Island Pharmaceuticals strengthens US biodefence push with new adviser Mark Herzog, MC2 roles, and Galidesivir progress toward FDA Animal Rule trials.
Biotechnology
Island Pharma Expands Antiviral Pipeline with Burnet Institute Collaboration and NHMRC Funding
Island Pharma expands antiviral pipeline with Burnet Institute; NHMRC grant of over $780k to back ISLA-101, accelerating Galidesivir MVD program.
Biotechnology
Island Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal Rule
Island Pharma signs a 3-year CRADA with USAMRIID and Geneva Foundation to fast-track Galidesivir for Marburg under FDA Animal Rule, eyeing NDA.